InspireMD (NSPR) Tops Q3 EPS by 2c

InspireMD (NYSE: NSPR) reported Q3 EPS of ($0.48), $0.02 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $632 thousand versus the consensus estimate of $900 thousand.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook
• Lonza Group (LONN:SW) (LZAGY) PT Raised to CHF720 at RBC Capital